Estrogen metabolites and breast cancer

Steroids

Volumn 99, Issue Part A, 2015, Pages 61-66

  Santen, Richard J ^a   Yue, Wei ^a   Wang, Ji Ping ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Adducts; Aromatase; Breast cancer; Estrogen; Genotoxic; Metabolites

Indexed keywords

AROMATASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; LETROZOLE; OXYGEN RADICAL; WNT1 PROTEIN; AROMATASE INHIBITOR; ESTROGEN RECEPTOR; WNT1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BREAST CANCER; BREAST CELL; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CASTRATED FEMALE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA ADDUCT; DNA REPAIR; DRUG MEGADOSE; ESTRADIOL BLOOD LEVEL; ESTROGEN SYNTHESIS; FEMALE; FOLLICULAR PHASE; GENE MUTATION; GENOTOXICITY; HUMAN; HUMAN CELL; MAMMARY GLAND; MENARCHE; MENOPAUSE; NONHUMAN; OBESITY; OVARIECTOMY; REVIEW; RISK FACTOR; SURVIVAL TIME; UTERUS WEIGHT; ANIMAL; BREAST NEOPLASMS; DISEASE FREE SURVIVAL; GENETICS; KNOCKOUT MOUSE; MCF 7 CELL LINE; METABOLISM; MORTALITY; TRANSGENIC MOUSE; UDDER;

ANIMALIA; MUS;

ANIMALS; AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MCF-7 CELLS; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, ESTROGEN; WNT1 PROTEIN;

EID: 84929838884     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2014.08.003     Document Type: Review

References (27)

1. R.J. Santen, N.F. Boyd, R.T. Chlebowski, S. Cummings, J. Cuzick, and M. Dowsett Breast cancer prevention collaborative group critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model Endocr Relat Cancer 14 2007 169 187
2. M. Feinleib Breast cancer and artificial menopause: a cohort study J Natl Cancer Inst 41 1968 315 329
3. T. Key, P. Appleby, I. Barnes, and G. Reeves Endogenous hormones and breast cancer collaborative group endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 2002 606 616
4. R. Kaaks, S. Rinaldi, T.J. Key, F. Berrino, P.H. Peeters, and C. Biessy Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition Endocr Relat Cancer 12 4 2005 1071 1082
5. J. Cuzick, T. Powles, U. Veronesi, J. Forbes, R. Edwards, and S. Ashley Overview of the main outcomes in breast-cancer prevention trials. [Review] [9 Refs.] Lancet 361 9354 2003 296 300
6. P.E. Goss, J.N. Ingle, A.M. Cheung, R.T. Chlebowski, J. Wactawski-Wende, and A. McTiernan NCIC CTG MAP exemestane for breast-cancer prevention in postmenopausal women N Engl J Med 364 2011 2381 2391
7. Cuzick J. SestakI FDMe 2014 Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS II): an international, double-blind, randomized placebo-controlled trial; online http://dx.doi.org/10.1016/S0140-6736(13)62292-8
8. B. Fisher, J.P. Costantino, D.L. Wickerham, C.K. Redmond, M. Kavanah, and W.M. Cronin Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. [See comment] J Natl Cancer Inst 90 18 1998 1371 1388
9. R.J. Santen, D.C. Allred, S.P. Ardoin, D.F. Archer, N. Boyd, and G.D. Braunstein Endocrine society postmenopausal hormone therapy: an Endocrine Society scientific statement. [Review] [511 refs] J Clin Endocrinol Metab 95 Suppl. 1 2010 S1 S66
10. S. Preston-Martin, M.C. Pike, R.K. Ross, P.A. Jones, and B.E. Henderson Increased cell division as a cause of human cancer Cancer Res 50 1990 7415 7421
11. L.J. Hofseth, A.M. Raafat, J.R. Osuch, D.R. Pathak, C.A. Slomski, and S.Z. Haslam Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast J Clin Endocrinol Metab 84 1999 4559 4565
12. J.D. Yager, and N.E. Davidson Estrogen carcinogenesis in breast cancer. [see comment]. [Review] [114 Refs.] N Engl J Med 354 2006 270 282
13. Yager JD. Endogenous estrogens as carcinogens through metabolic activation. [Review] [54 Refs.]. J Natl Cancer Inst Monogr 2000; 67-73.
14. E.L. Cavalieri, and E.G. Rogan Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer. [Review] J Steroid Biochem Mol Biol 125 2011 169 180
15. J.A. Lavigne, J.E. Goodman, T. Fonong, S. Odwin, P. He, and D.W. Roberts The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells Cancer Res 61 2001 7488 7494
16. E. Cavalieri, D. Chakravarti, J. Guttenplan, E. Hart, J. Ingle, and R. Jankowiak Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. [Review] [102 Refs.] Biochim Biophys Acta 1766 2006 63 78
17. W.P. Bocchinfuso, W.P. Hively, J.F. Couse, H.E. Varmus, and K.S. Korach A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha Cancer Res 59 1999 1869 1876
18. W. Yue, J.P. Wang, P. Fan, G. Liu, N. Zhang, and M. Conaway Effects of estrogen on breast cancer development Int J Cancer 127 8 2010 1748 1757
19. P. Devanesan, R.J. Santen, W.P. Bocchinfuso, K.S. Korach, E.G. Rogan, and E. Cavalieri Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors Carcinogenesis 22 2001 1573 1576
20. W. Yue, R.J. Santen, J.P. Wang, Y. Li, M.F. Verderame, and W.P. Bocchinfuso Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. [Review] [42 Refs.] J Steroid Biochem Mol Biol 86 2003 477 486
21. W. Yue, J.D. Yager, J.P. Wang, E.R. Jupe, and R.J. Santen Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis Steroids. 78 2 2013 161 170
22. T.J. Key, P.K. Verkasalo, and E. Banks Epidemiology of breast cancer. [Review] [50 Refs.] Lancet Oncol 2 3 2001 133 140
23. J.D. Yager, and J.G. Liehr Molecular mechanisms of estrogen carcinogenesis. [Review] [226 Refs.] Annu Rev Pharmacol Toxicol 36 1996 203 232
24. E.L. Cavalieri, and E.G. Rogan Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. [Review] [94 Refs.] Future Oncol 6 2010 75 91
25. L.M. Berstein, W. Yue, J.P. Wang, and R.J. Santen Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells Breast Cancer Res Treat 128 2011 109 117
26. J. Russo, S.V. Fernandez, P.A. Russo, R. Fernbaugh, F.S. Sheriff, and H.M. Lareef 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells FASEB J 20 2006 1622 1634
27. J. Russo, and I.H. Russo The role of estrogen in the initiation of breast cancer. [Review] [83 Refs.] J Steroid Biochem Mol Biol 102 2006 89 96